Development of eugenol derivatives with 5-LOX inhibitory activity
| dc.contributor.author | Filho, José L. Pereira | por |
| dc.contributor.author | Pereira, Renato B. | por |
| dc.contributor.author | Vieira, Tatiana F. | por |
| dc.contributor.author | Sousa, Sérgio F. | por |
| dc.contributor.author | Coelho, José Ricardo Alves | por |
| dc.contributor.author | Pinto, Nuno F. S. | por |
| dc.contributor.author | Coelho, Catarina M. M. | por |
| dc.contributor.author | Fernandes, Maria José Gomes | por |
| dc.contributor.author | Castanheira, Elisabete M. S. | por |
| dc.contributor.author | Gonçalves, M. Sameiro T. | por |
| dc.contributor.author | Pereira, David M. | por |
| dc.date.accessioned | 2025-09-05T10:43:52Z | |
| dc.date.available | 2025-09-05T10:43:52Z | |
| dc.date.issued | 2025-08-21 | |
| dc.description.abstract | Eugenol (4-allyl-2-methoxyphenol), is the major chemical constituent in the essential oil of numerous plant species. Several biological properties have been described for this molecule, including modulation of enzymatic targets relevant for the inflammatory response, such as 5-lipoxygenase (5-LOX). As so, there is interest in expanding the chemical space of this molecule to develop new molecules to be used in inflammatory conditions. We describe the chemometric analysis of several eugenol derivatives, which show that the chemical space of the parent molecule was successfully expanded. All molecules were evaluated for their inhibition towards 5-LOX, an important player in inflammatory pathways. Four derivatives exhibited significant 5-LOX inhibitory activity, which prompted further studies. The most promising compounds, 4-allylbenzene-1,2-diol 2, ethyl-4-(4-allyl-2-methoxyphenoxy)butanoate 4e, 3-(2-methoxy-4-(oxiran-2-ylmethyl)phenoxy)propyl acetate 5d and 4-(3-(tert-butoxy)-2-hydroxypropyl)-2-methoxyphenol 7c, were submitted to in silico assays to validate their affinity and stability towards 5-LOX, which helped clarify the mechanism by which these molecules interact and inhibit this enzyme. | por |
| dc.description.sponsorship | The work was supported through projects UIDB/50006/2020, UIDP/50006/2020 and PTDC/ASP-AGR/30154/2017 (PO-CI-01–0145-FEDER-030154) of COMPETE 2020, funded by FCT (Fundação para a Ciência e Tecnologia, Portugal)/MCTES (Ministério da Ciência, Tecnologia e Ensino Superior) through national funds. Renato B. Pereira thanks FCT - Fundação para Ciência e a Tecnologia, I.P. for the funding through project PTDC-QUI/2870/2020. The authors acknowledge also to FCT, and FEDER-COMPETE-QREN-EU for financial support to the research centre CQUM (UID/QUI/00686/2020). The NMR spectrometer Bruker Avance III 400 is part of the National NMR Network (PTNMR) and is partially supported by Infrastructure Project No 022161 (co-financed by FEDER through COMPETE 2020, POCI and PORL and FCT through PIDDAC). | por |
| dc.distribution | international | por |
| dc.identifier.articlenumber | 2535586 | por |
| dc.identifier.citation | José L. Pereira Filho, Renato B. Pereira, Tatiana F. Vieira, Sérgio F. Sousa, José R. A. Coelho, Nuno F. S. Pinto, Catarina M. M. Coelho, Maria José G. Fernandes, Elisabete M. S. Castanheira, Maria S. T. Gonçalves & David M. Pereira (2025) Development of eugenol derivatives with 5-LOX inhibitory activity, Journal of Enzyme Inhibition and Medicinal Chemistry, 40:1, 2535586, DOI: 10.1080/14756366.2025.2535586 | por |
| dc.identifier.doi | 10.1080/14756366.2025.2535586 | por |
| dc.identifier.issn | 1475-6366 | por |
| dc.identifier.pmid | 40842071 | por |
| dc.identifier.uri | https://hdl.handle.net/1822/97043 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Taylor & Francis | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/3599-PPCDT/PTDC%2FQUI-QFI%2F2870%2F2020/PT | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/9471 - RIDTI/PTDC%2FASP-AGR%2F30154%2F2017/PT | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F50006%2F2020/PT | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F00686%2F2020/PT | por |
| dc.relation | info:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04650%2F2020/PT | por |
| dc.relation.publisherversion | https://www.tandfonline.com/doi/full/10.1080/14756366.2025.2535586 | por |
| dc.rights | openAccess | por |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | por |
| dc.subject | Chemometrics | por |
| dc.subject | Eugenol | por |
| dc.subject | 5-Lipoxygenase | por |
| dc.subject | In silico | por |
| dc.subject.fos | Ciências Médicas::Ciências da Saúde | por |
| dc.subject.fos | Ciências Naturais::Ciências Químicas | por |
| dc.subject.ods | Saúde de qualidade | por |
| dc.subject.ods | Cidades e comunidades sustentáveis | por |
| dc.subject.ods | Produção e consumo sustentáveis | por |
| dc.subject.ods | Proteger a vida terrestre | por |
| dc.title | Development of eugenol derivatives with 5-LOX inhibitory activity | por |
| dc.type | article | por |
| dspace.entity.type | Publication | en |
| oaire.citationIssue | 1 | por |
| oaire.citationVolume | 40 | por |
| oaire.version | VoR | por |
| sdum.journal | Journal of Enzyme Inhibition and Medicinal Chemistry | por |
Ficheiros
Pacote original
1 - 2 de 2
A carregar...
- Nome:
- Development of eugenol derivatives with 5-LOX inhibitory activity.pdf
- Tamanho:
- 7.66 MB
- Formato:
- Adobe Portable Document Format
- Descrição:
- Article
A carregar...
- Nome:
- Supplementary Info.pdf
- Tamanho:
- 765.93 KB
- Formato:
- Adobe Portable Document Format
- Descrição:
- Supplementary Info